Original data (with adjusted standard errors for multi-arm studies):

                                                            treat1              treat2      TE   seTE seTE.adj.f seTE.adj.r narms multiarm
0462-039 1996                                              placebo  rizatriptan (high) -1.1713 0.3216     0.4027     0.4787     3        *
0462-039 1996                                              placebo   rizatriptan (low) -0.8402 0.3300     0.4326     0.5010     3        *
0462-039 1996                                   rizatriptan (high)   rizatriptan (low)  0.3311 0.2768     0.3133     0.4010     3        *
103 UN                                            eletriptan (low)             placebo  1.7970 0.4314     0.4314     0.4795     2         
Ahrens 1999                                                placebo  rizatriptan (high) -1.9057 0.2887     0.3725     0.4541     3        *
Ahrens 1999                                                placebo   rizatriptan (low) -1.5916 0.2930     0.3927     0.4666     3        *
Ahrens 1999                                     rizatriptan (high)   rizatriptan (low)  0.3141 0.2147     0.2339     0.3378     3        *
Ashina 2021                                      lasmiditan (high)    lasmiditan (low)  0.2144 0.1480     0.1613     0.2948     3        *
Ashina 2021                                      lasmiditan (high)             placebo  1.4362 0.1983     0.2554     0.3635     3        *
Ashina 2021                                       lasmiditan (low)             placebo  1.2217 0.2015     0.2705     0.3706     3        *
Barbanti 2012                                              placebo  rizatriptan (high) -2.4814 0.6686     0.6686     0.7006     2         
Bomhof 1999                                     naratriptan (high)             placebo  1.0361 0.3872     0.5678     0.6049     3        *
Bomhof 1999                                     naratriptan (high)  rizatriptan (high) -1.1419 0.2207     0.2312     0.3277     3        *
Bomhof 1999                                                placebo  rizatriptan (high) -2.1780 0.3761     0.4762     0.5517     3        *
Brandes 2005                                      eletriptan (low)             placebo  0.8562 0.1995     0.1995     0.2891     2         
Brandes 2007a                                naproxen sodium (low)             placebo  0.5322 0.2334     0.3233     0.4054     3        *
Brandes 2007a                                naproxen sodium (low)  sumatriptan (high) -0.6483 0.1892     0.2124     0.3290     3        *
Brandes 2007a                                              placebo  sumatriptan (high) -1.1805 0.2170     0.2620     0.3692     3        *
Brandes 2007b                                naproxen sodium (low)             placebo  0.4863 0.2230     0.2990     0.3901     3        *
Brandes 2007b                                naproxen sodium (low)  sumatriptan (high) -0.4323 0.1877     0.2133     0.3306     3        *
Brandes 2007b                                              placebo  sumatriptan (high) -0.9186 0.2111     0.2580     0.3654     3        *
Brauneis 1994                                              placebo  sumatriptan (high) -3.1600 1.6127     1.6127     1.6262     2         
Bussone 2000                                               placebo   sumatriptan (low) -1.3393 0.4652     0.4652     0.5101     2         
Cady 2006a                                                 placebo  rizatriptan (high) -1.0065 0.1888     0.1888     0.2819     2         
Cady 2006b                                                 placebo  rizatriptan (high) -1.0359 0.1930     0.1930     0.2847     2         
Cady 2009                                                  placebo  rizatriptan (high) -1.3734 0.4455     0.4455     0.4922     2         
Carpay 2004                                                placebo  sumatriptan (high) -1.8505 0.2587     0.3299     0.4176     3        *
Carpay 2004                                                placebo   sumatriptan (low) -1.2303 0.2575     0.3259     0.4149     3        *
Carpay 2004                                     sumatriptan (high)   sumatriptan (low)  0.6202 0.2268     0.2600     0.3624     3        *
Croop 2019                                                 placebo          rimegepant -0.7639 0.1542     0.1542     0.2599     2         
Cutler 1995                                                placebo  sumatriptan (high) -1.2611 0.5504     0.8170     0.8363     3        *
Cutler 1995                                                placebo   sumatriptan (low) -1.0186 0.5176     0.6299     0.6879     3        *
Cutler 1995                                     sumatriptan (high)   sumatriptan (low)  0.2426 0.3709     0.3975     0.4632     3        *
Dahlöf 1998                                                placebo zolmitriptan (high) -3.8038 1.0136     1.0136     1.0350     2         
Dahlöf 2001                                     almotriptan (high)   almotriptan (low)  0.4272 0.2256     0.2369     0.3320     3        *
Dahlöf 2001                                     almotriptan (high)             placebo  1.5705 0.3817     0.5007     0.5678     3        *
Dahlöf 2001                                      almotriptan (low)             placebo  1.1433 0.3868     0.5403     0.5914     3        *
Dahlöf 2009                                                placebo   sumatriptan (low) -1.5436 0.4123     0.4123     0.4624     2         
Diener 2002                                      eletriptan (high)    eletriptan (low)  0.4276 0.2095     0.2149     0.3098     3        *
Diener 2002                                      eletriptan (high)             placebo  2.4699 0.4795     0.6378     0.6975     3        *
Diener 2002                                       eletriptan (low)             placebo  2.0422 0.4834     0.6949     0.7281     3        *
Diener 2004                                   acetylsalicylic acid             placebo  0.6946 0.2987     0.3702     0.4508     3        *
Diener 2004                                   acetylsalicylic acid   sumatriptan (low)  0.0389 0.2761     0.3217     0.4099     3        *
Diener 2004                                                placebo   sumatriptan (low) -0.6557 0.3053     0.3901     0.4660     3        *
Diener 2005                                   diclofenac potassium             placebo  1.2668 0.4265     0.4265     0.4751     2         
Diener 2011                                       eletriptan (low)             placebo  1.6487 0.4877     0.4877     0.5307     2         
Dodick 2019                                                placebo   ubrogepant (high) -0.6539 0.1822     0.2263     0.3426     3        *
Dodick 2019                                                placebo    ubrogepant (low) -0.4667 0.1869     0.2414     0.3512     3        *
Dodick 2019                                      ubrogepant (high)    ubrogepant (low)  0.1872 0.1647     0.1900     0.3172     3        *
Dowson 2002a                                    almotriptan (high)             placebo  0.7642 0.3251     0.4448     0.5088     3        *
Dowson 2002a                                    almotriptan (high)  sumatriptan (high) -0.2731 0.2242     0.2414     0.3407     3        *
Dowson 2002a                                               placebo  sumatriptan (high) -1.0373 0.3189     0.4108     0.4877     3        *
Dowson 2002b                                               placebo  zolmitriptan (low) -1.3773 0.2896     0.2896     0.3573     2         
Eletriptan Steering Committee in Japan 2002      eletriptan (high)    eletriptan (low)  0.2559 0.3183     0.3493     0.4271     3        *
Eletriptan Steering Committee in Japan 2002      eletriptan (high)             placebo  1.0207 0.4231     0.6216     0.6540     3        *
Eletriptan Steering Committee in Japan 2002       eletriptan (low)             placebo  0.7647 0.3865     0.4599     0.5317     3        *
Ensink 1991                                                placebo  sumatriptan (high) -1.9238 0.5457     0.5457     0.5845     2         
Färkkila 2003                                    eletriptan (high)    eletriptan (low)  0.3949 0.2257     0.2324     0.3230     3        *
Färkkila 2003                                    eletriptan (high)             placebo  2.2833 0.4870     0.6642     0.7142     3        *
Färkkila 2003                                     eletriptan (low)             placebo  1.8884 0.4880     0.6775     0.7219     3        *
Färkkila 2012                                    lasmiditan (high)    lasmiditan (low)  0.2444 0.3731     0.4057     0.4726     3        *
Färkkila 2012                                    lasmiditan (high)             placebo  0.8820 0.5152     0.7574     0.7817     3        *
Färkkila 2012                                     lasmiditan (low)             placebo  0.6376 0.4772     0.5739     0.6345     3        *
Freitag 2008                                    paracetamol (high)             placebo  0.7564 0.5549     0.7442     0.7835     3        *
Freitag 2008                                    paracetamol (high)  rizatriptan (high) -0.6122 0.4572     0.5153     0.5722     3        *
Freitag 2008                                               placebo  rizatriptan (high) -1.3687 0.5301     0.6540     0.7042     3        *
Garcia-Ramos 2003                                 eletriptan (low)  naratriptan (high)  0.7130 0.2334     0.2534     0.3512     3        *
Garcia-Ramos 2003                                 eletriptan (low)             placebo  0.8473 0.3091     0.3813     0.4652     3        *
Garcia-Ramos 2003                               naratriptan (high)             placebo  0.1343 0.3255     0.4628     0.5175     3        *
Geraud 2000                                                placebo  sumatriptan (high) -1.1082 0.4081     0.5650     0.6232     3        *
Geraud 2000                                                placebo zolmitriptan (high) -1.0737 0.4085     0.5743     0.6261     3        *
Geraud 2000                                     sumatriptan (high) zolmitriptan (high)  0.0345 0.1336     0.1355     0.2587     3        *
Gijsmant 1997                                              placebo  rizatriptan (high) -2.5242 0.7379     0.9726     1.0232     3        *
Gijsmant 1997                                              placebo   rizatriptan (low) -2.1301 0.7440     1.0985     1.1042     3        *
Gijsmant 1997                                   rizatriptan (high)   rizatriptan (low)  0.3941 0.2720     0.2768     0.3525     3        *
Goadsby 2000                                     eletriptan (high)    eletriptan (low)  0.4852 0.2258     0.2656     0.3786     4        *
Goadsby 2000                                     eletriptan (high)             placebo  2.0661 0.4237     0.7161     0.7600     4        *
Goadsby 2000                                     eletriptan (high)  sumatriptan (high)  0.4432 0.2667     0.3739     0.4597     4        *
Goadsby 2000                                      eletriptan (low)             placebo  1.5809 0.4117     0.5874     0.6839     4        *
Goadsby 2000                                      eletriptan (low)  sumatriptan (high) -0.0420 0.2473     0.3067     0.4136     4        *
Goadsby 2000                                               placebo  sumatriptan (high) -1.6229 0.4355     0.8268     0.8304     4        *
Goadsby 2007                                    almotriptan (high)  zolmitriptan (low) -0.1967 0.1233     0.1233     0.2429     2         
Goadsby 2008                                    almotriptan (high)             placebo  1.0695 0.2158     0.2158     0.3006     2         
Goadsby 2019                                     lasmiditan (high)    lasmiditan (low)  0.3069 0.1031     0.1148     0.2782     3        *
Goadsby 2019                                     lasmiditan (high)             placebo  0.7325 0.1303     0.1860     0.3106     3        *
Goadsby 2019                                      lasmiditan (low)             placebo  0.4256 0.1191     0.1420     0.2950     3        *
Göbel 2004                                               phenazone             placebo  0.8808 0.3554     0.3554     0.4125     2         
Goldstein 2006                                    ibuprofen (high)             placebo  0.2420 0.1777     0.1777     0.2746     2         
Gomez-Mancilla 2014                                        placebo  sumatriptan (high) -0.5055 0.7190     0.7190     0.7488     2         
Gruffyd-Jones 2001                               sumatriptan (low) zolmitriptan (high) -0.0254 0.1249     0.1509     0.2974     3        *
Gruffyd-Jones 2001                               sumatriptan (low)  zolmitriptan (low)  0.1949 0.1276     0.1574     0.3008     3        *
Gruffyd-Jones 2001                             zolmitriptan (high)  zolmitriptan (low)  0.2203 0.1275     0.1572     0.3007     3        *
Ho 2008a                                                   placebo  rizatriptan (high) -0.9741 0.4364     0.4364     0.4840     2         
Ho 2008b                                                   placebo zolmitriptan (high) -1.4082 0.2223     0.2223     0.3053     2         
Jelinski 2006                                              placebo  sumatriptan (high) -1.6943 0.3177     0.4091     0.4835     3        *
Jelinski 2006                                              placebo   sumatriptan (low) -1.3244 0.3200     0.4184     0.4899     3        *
Jelinski 2006                                   sumatriptan (high)   sumatriptan (low)  0.3699 0.2538     0.2817     0.3746     3        *
Kaniecki 2006                                              placebo  sumatriptan (high) -0.6463 0.3178     0.3178     0.3805     2         
Kellstein 2000                                    ibuprofen (high)     ibuprofen (low)  0.1165 0.1905     0.2029     0.3155     3        *
Kellstein 2000                                    ibuprofen (high)             placebo  0.9219 0.2641     0.3109     0.4133     3        *
Kellstein 2000                                     ibuprofen (low)             placebo  0.8053 0.2883     0.4578     0.4892     3        *
Klapper 2004                                               placebo  zolmitriptan (low) -1.1449 0.2726     0.2726     0.3437     2         
Klassen 1997                                    naratriptan (high)   naratriptan (low)  0.5875 0.3706     0.4395     0.5092     3        *
Klassen 1997                                    naratriptan (high)             placebo  0.5464 0.3627     0.4244     0.4953     3        *
Klassen 1997                                     naratriptan (low)             placebo -0.0410 0.4061     0.5435     0.5965     3        *
Kramer 1998                                                placebo  rizatriptan (high) -2.1889 0.4350     0.4350     0.4827     2         
Kuca 2018                                        lasmiditan (high)    lasmiditan (low)  0.2029 0.1281     0.1457     0.2924     3        *
Kuca 2018                                        lasmiditan (high)             placebo  0.8717 0.1474     0.1848     0.3167     3        *
Kuca 2018                                         lasmiditan (low)             placebo  0.6688 0.1507     0.1962     0.3219     3        *
Landy 2004                                                 placebo  sumatriptan (high) -1.5192 0.2476     0.3151     0.4061     3        *
Landy 2004                                                 placebo   sumatriptan (low) -1.2834 0.2468     0.3125     0.4043     3        *
Landy 2004                                      sumatriptan (high)   sumatriptan (low)  0.2358 0.2181     0.2504     0.3558     3        *
Lange 2000                                    acetylsalicylic acid             placebo  0.7138 0.2648     0.2648     0.3375     2         
Lines 2001                                                 placebo   rizatriptan (low) -2.5257 0.7248     1.0513     1.0621     3        *
Lines 2001                                                 placebo   sumatriptan (low) -2.7243 0.7237     0.9877     1.0379     3        *
Lines 2001                                       rizatriptan (low)   sumatriptan (low) -0.1986 0.1601     0.1611     0.2678     3        *
Lipton 2000                                     paracetamol (high)             placebo  0.8300 0.3257     0.3257     0.3872     2         
Lipton 2005                                   acetylsalicylic acid             placebo  1.1956 0.3243     0.3243     0.3860     2         
Lipton 2010                                   diclofenac potassium             placebo  1.0450 0.2146     0.2146     0.2998     2         
Lipton 2019a                                             celecoxib             placebo  0.7180 0.1907     0.1907     0.2832     2         
Lipton 2019b                                               placebo    ubrogepant (low) -0.5777 0.1772     0.1772     0.2742     2         
Lipton 2019c                                               placebo          rimegepant -0.5718 0.1706     0.1706     0.2700     2         
Lipton 2021                                              celecoxib             placebo  0.3814 0.1841     0.1841     0.2787     2         
Loder 2005                                                 placebo  zolmitriptan (low) -0.9695 0.1886     0.1886     0.2818     2         
Marcus 2014                                                placebo          rimegepant -0.9912 0.3000     0.3697     0.4503     3        *
Marcus 2014                                                placebo  sumatriptan (high) -1.1056 0.2818     0.3305     0.4171     3        *
Marcus 2014                                             rimegepant  sumatriptan (high) -0.1143 0.3078     0.3926     0.4681     3        *
Massiou 2005                                    naratriptan (high)             placebo  0.8053 0.2805     0.2805     0.3500     2         
Mathew 2003                                       eletriptan (low)             placebo  2.2143 0.2340     0.3100     0.4095     3        *
Mathew 2003                                       eletriptan (low)  sumatriptan (high)  0.3988 0.1049     0.1077     0.2555     3        *
Mathew 2003                                                placebo  sumatriptan (high) -1.8155 0.2362     0.3402     0.4171     3        *
Mathew 2007                                     almotriptan (high)             placebo  0.6475 0.2409     0.2409     0.3191     2         
MOMENTUM 2019                                              placebo  rizatriptan (high) -1.0673 0.3040     0.3040     0.3691     2         
Moon 2010                                             frovatriptan             placebo  1.4703 0.4744     0.4744     0.5185     2         
Munjal 2017                                              celecoxib             placebo  1.5581 0.8757     0.8757     0.9004     2         
Myllylä 1998                                               placebo  sumatriptan (high) -2.5337 0.6657     0.6657     0.6978     2         
Nappi 1994                                                 placebo  sumatriptan (high) -0.7350 0.3829     0.3829     0.4363     2         
NCT00920686 2010                                           placebo  sumatriptan (high) -0.1054 0.4437     0.4437     0.4905     2         
NCT01248468 2011                                           placebo  sumatriptan (high) -0.7996 0.2319     0.2319     0.3124     2         
NCT01657370 2012                                           placebo   ubrogepant (high) -2.1076 1.5332     2.5576     2.5220     3        *
NCT01657370 2012                                           placebo    ubrogepant (low) -3.0676 1.4783     1.7800     1.8140     3        *
NCT01657370 2012                                 ubrogepant (high)    ubrogepant (low) -0.9601 0.6901     0.7076     0.7414     3        *
NCT01986270 / 104 1998                           eletriptan (high)    eletriptan (low)  0.3857 0.2563     0.2712     0.3583     3        *
NCT01986270 / 104 1998                           eletriptan (high)             placebo  1.2646 0.4079     0.5279     0.5926     3        *
NCT01986270 / 104 1998                            eletriptan (low)             placebo  0.8789 0.4157     0.5826     0.6286     3        *
NCT03235479 2018                                           placebo          rimegepant -0.3516 0.1633     0.1633     0.2655     2         
Nett 2003                                                  placebo  sumatriptan (high) -0.9077 0.2617     0.3283     0.4165     3        *
Nett 2003                                                  placebo   sumatriptan (low) -0.7692 0.2612     0.3268     0.4154     3        *
Nett 2003                                       sumatriptan (high)   sumatriptan (low)  0.1385 0.2426     0.2847     0.3820     3        *
Pascual 2000a                                   almotriptan (high)   almotriptan (low)  0.4640 0.1538     0.1640     0.2916     3        *
Pascual 2000a                                   almotriptan (high)             placebo  1.2678 0.2313     0.2980     0.3972     3        *
Pascual 2000a                                    almotriptan (low)             placebo  0.8038 0.2361     0.3279     0.4107     3        *
Pascual 2000b                                              placebo  rizatriptan (high) -1.9349 0.3033     0.4048     0.4825     3        *
Pascual 2000b                                              placebo  zolmitriptan (low) -1.6340 0.3054     0.4233     0.4910     3        *
Pascual 2000b                                   rizatriptan (high)  zolmitriptan (low)  0.3009 0.1677     0.1750     0.2912     3        *
Prior 2010                                      paracetamol (high)             placebo  0.5861 0.3534     0.3534     0.4107     2         
Rapoport 1997                                              placebo zolmitriptan (high) -1.8519 0.3854     0.5180     0.5828     3        *
Rapoport 1997                                              placebo  zolmitriptan (low) -1.6433 0.3875     0.5434     0.5953     3        *
Rapoport 1997                                  zolmitriptan (high)  zolmitriptan (low)  0.2086 0.1871     0.1931     0.2981     3        *
Rapoport 2002                                         frovatriptan             placebo  1.5766 0.4607     0.4607     0.5060     2         
Ryan 2002a                                            frovatriptan             placebo  1.9446 0.7424     0.7424     0.7713     2         
Ryan 2002b                                            frovatriptan             placebo  1.6724 0.3552     0.3552     0.4123     2         
Ryan 2002c                                            frovatriptan             placebo  1.0956 0.4169     0.6652     0.6653     3        *
Ryan 2002c                                            frovatriptan  sumatriptan (high) -0.8005 0.2045     0.2110     0.3102     3        *
Ryan 2002c                                                 placebo  sumatriptan (high) -1.8961 0.4019     0.4916     0.5759     3        *
S2WB3002 1996                                   naratriptan (high)   naratriptan (low)  0.7189 0.2775     0.3963     0.4725     4        *
S2WB3002 1996                                   naratriptan (high)             placebo  1.6094 0.4871     0.8273     0.8587     4        *
S2WB3002 1996                                   naratriptan (high)  sumatriptan (high) -0.6688 0.2198     0.2504     0.3624     4        *
S2WB3002 1996                                    naratriptan (low)             placebo  0.8905 0.5057     1.0564     1.0016     4        *
S2WB3002 1996                                    naratriptan (low)  sumatriptan (high) -1.3877 0.2584     0.3197     0.4227     4        *
S2WB3002 1996                                              placebo  sumatriptan (high) -2.2782 0.4765     0.6674     0.7682     4        *
Sakai 2002                                                 placebo zolmitriptan (high) -0.7444 0.5080     0.6288     0.6797     3        *
Sakai 2002                                                 placebo  zolmitriptan (low) -0.4308 0.5220     0.6725     0.7187     3        *
Sakai 2002                                     zolmitriptan (high)  zolmitriptan (low)  0.3137 0.4650     0.5388     0.5952     3        *
Sakai 2021                                       lasmiditan (high)    lasmiditan (low)  0.4933 0.1887     0.2121     0.3286     3        *
Sakai 2021                                       lasmiditan (high)             placebo  1.1655 0.2316     0.3146     0.4009     3        *
Sakai 2021                                        lasmiditan (low)             placebo  0.6723 0.2193     0.2687     0.3737     3        *
Sandrini 2002                                    eletriptan (high)    eletriptan (low)  0.2845 0.2320     0.3048     0.4267     5        *
Sandrini 2002                                    eletriptan (high)             placebo  2.7194 0.6100     1.0834     1.1656     5        *
Sandrini 2002                                    eletriptan (high)  sumatriptan (high)  1.0050 0.2609     0.3757     0.4844     5        *
Sandrini 2002                                    eletriptan (high)   sumatriptan (low)  0.9243 0.2521     0.3547     0.4668     5        *
Sandrini 2002                                     eletriptan (low)             placebo  2.4349 0.6108     1.1014     1.1763     5        *
Sandrini 2002                                     eletriptan (low)  sumatriptan (high)  0.7205 0.2626     0.3820     0.4888     5        *
Sandrini 2002                                     eletriptan (low)   sumatriptan (low)  0.6398 0.2538     0.3606     0.4711     5        *
Sandrini 2002                                              placebo  sumatriptan (high) -1.7144 0.6223     1.3576     1.3352     5        *
Sandrini 2002                                              placebo   sumatriptan (low) -1.7951 0.6187     1.2818     1.2868     5        *
Sandrini 2002                                   sumatriptan (high)   sumatriptan (low) -0.0808 0.2804     0.4445     0.5348     5        *
Saper 2006                                        ibuprofen (high)             placebo  1.6452 0.3628     0.3628     0.4189     2         
Sargent 1995                                               placebo  sumatriptan (high) -1.5281 0.6896     1.0463     1.0531     3        *
Sargent 1995                                               placebo   sumatriptan (low) -1.2452 0.6517     0.7934     0.8431     3        *
Sargent 1995                                    sumatriptan (high)   sumatriptan (low)  0.2829 0.4338     0.4596     0.5157     3        *
Savani 1999                                                placebo   sumatriptan (low) -1.8165 0.4367     0.4367     0.4843     2         
Sheftell 2003                                    eletriptan (high)    eletriptan (low)  0.3536 0.1629     0.1687     0.2857     3        *
Sheftell 2003                                    eletriptan (high)             placebo  2.1676 0.3211     0.4887     0.5247     3        *
Sheftell 2003                                     eletriptan (low)             placebo  1.8140 0.3119     0.3910     0.4830     3        *
Sheftell 2005a                                             placebo  sumatriptan (high) -1.3143 0.1469     0.1858     0.3171     3        *
Sheftell 2005a                                             placebo   sumatriptan (low) -0.9938 0.1491     0.1934     0.3205     3        *
Sheftell 2005a                                  sumatriptan (high)   sumatriptan (low)  0.3206 0.1257     0.1423     0.2904     3        *
Sheftell 2005b                                             placebo  sumatriptan (high) -1.7588 0.1690     0.2194     0.3383     3        *
Sheftell 2005b                                             placebo   sumatriptan (low) -1.4821 0.1706     0.2266     0.3412     3        *
Sheftell 2005b                                  sumatriptan (high)   sumatriptan (low)  0.2767 0.1263     0.1378     0.2839     3        *
Smith 2005                                   naproxen sodium (low)             placebo  1.2006 0.3133     0.4097     0.4836     3        *
Smith 2005                                   naproxen sodium (low)   sumatriptan (low) -0.1081 0.2340     0.2555     0.3531     3        *
Smith 2005                                                 placebo   sumatriptan (low) -1.3086 0.3142     0.4138     0.4864     3        *
Solomon 1997                                               placebo  zolmitriptan (low) -0.8370 0.3912     0.3912     0.4437     2         
Spierings 2001                                  almotriptan (high)   sumatriptan (low) -0.3909 0.1429     0.1429     0.2534     2         
Stark 2002                                       eletriptan (high)    eletriptan (low)  0.1433 0.1424     0.1445     0.2635     3        *
Stark 2002                                       eletriptan (high)             placebo  2.9521 0.4251     0.5829     0.6427     3        *
Stark 2002                                        eletriptan (low)             placebo  2.8087 0.4260     0.6044     0.6501     3        *
Steiner 2003                                     eletriptan (high)    eletriptan (low)  0.4361 0.1450     0.1745     0.3193     4        *
Steiner 2003                                     eletriptan (high)             placebo  2.2645 0.3755     0.5903     0.6843     4        *
Steiner 2003                                     eletriptan (high)  zolmitriptan (low)  0.6429 0.1492     0.1838     0.3253     4        *
Steiner 2003                                      eletriptan (low)             placebo  1.8284 0.3781     0.6480     0.7053     4        *
Steiner 2003                                      eletriptan (low)  zolmitriptan (low)  0.2068 0.1557     0.2017     0.3352     4        *
Steiner 2003                                               placebo  zolmitriptan (low) -1.6216 0.3797     0.6823     0.7184     4        *
SUM20033 2003                                              placebo  sumatriptan (high) -1.0210 0.3352     0.3352     0.3952     2         
Tazaki 1993                                                placebo  sumatriptan (high) -0.8448 0.4314     0.4314     0.4795     2         
Teall 1996                                                 placebo  rizatriptan (high) -1.8155 0.2104     0.2756     0.3796     3        *
Teall 1996                                                 placebo   rizatriptan (low) -1.4370 0.2131     0.2948     0.3868     3        *
Teall 1996                                      rizatriptan (high)   rizatriptan (low)  0.3785 0.1309     0.1384     0.2773     3        *
Tfelt-Hansen 1995                                          placebo  sumatriptan (high) -1.4904 0.3813     0.3813     0.4349     2         
Tfelt-Hansen 1998                                          placebo  rizatriptan (high) -1.7253 0.2874     0.4127     0.5234     4        *
Tfelt-Hansen 1998                                          placebo   rizatriptan (low) -1.1648 0.3231     0.7415     0.6800     4        *
Tfelt-Hansen 1998                                          placebo  sumatriptan (high) -1.4369 0.2894     0.4361     0.5327     4        *
Tfelt-Hansen 1998                               rizatriptan (high)   rizatriptan (low)  0.5605 0.2034     0.2719     0.3933     4        *
Tfelt-Hansen 1998                               rizatriptan (high)  sumatriptan (high)  0.2885 0.1439     0.1599     0.3081     4        *
Tfelt-Hansen 1998                                rizatriptan (low)  sumatriptan (high) -0.2721 0.2062     0.2872     0.4003     4        *
Tfelt-Hansen 2006                                          placebo   sumatriptan (low) -1.0806 0.4561     0.4561     0.5018     2         
Toledano 2021                                    paracetamol (low)             placebo  0.4700 0.6892     0.6892     0.7203     2         
Visser 1996a                                               placebo  rizatriptan (high) -2.2539 0.6357     0.8101     0.8587     3        *
Visser 1996a                                               placebo  sumatriptan (high) -2.0553 0.6526     0.9484     0.9676     3        *
Visser 1996a                                    rizatriptan (high)  sumatriptan (high)  0.1986 0.3728     0.3907     0.4530     3        *
Visser 1996b                                               placebo zolmitriptan (high) -1.1527 1.2006     1.2006     1.2187     2         
Voss 2016                                                  placebo   ubrogepant (high) -1.0791 0.3937     0.4992     0.5629     3        *
Voss 2016                                                  placebo    ubrogepant (low) -0.8861 0.4022     0.5338     0.5898     3        *
Voss 2016                                        ubrogepant (high)    ubrogepant (low)  0.1930 0.3182     0.3534     0.4307     3        *
Wentz 2008                                  naproxen sodium (high)             placebo  1.6923 0.4472     0.4472     0.4938     2         
Winner 2003a                                               placebo  sumatriptan (high) -0.9135 0.2610     0.3262     0.4149     3        *
Winner 2003a                                               placebo   sumatriptan (low) -0.8249 0.2617     0.3282     0.4164     3        *
Winner 2003a                                    sumatriptan (high)   sumatriptan (low)  0.0887 0.2431     0.2858     0.3829     3        *
Winner 2003b                                               placebo  sumatriptan (high) -1.1084 0.2652     0.3280     0.4164     3        *
Winner 2003b                                               placebo   sumatriptan (low) -0.9640 0.2676     0.3346     0.4213     3        *
Winner 2003b                                    sumatriptan (high)   sumatriptan (low)  0.1444 0.2537     0.3018     0.3954     3        *
Yu 2023                                                    placebo          rimegepant -0.7024 0.1573     0.1573     0.2618     2         

Number of treatment arms (by study):
                                            narms
0462-039 1996                                   3
103 UN                                          2
Ahrens 1999                                     3
Ashina 2021                                     3
Barbanti 2012                                   2
Bomhof 1999                                     3
Brandes 2005                                    2
Brandes 2007a                                   3
Brandes 2007b                                   3
Brauneis 1994                                   2
Bussone 2000                                    2
Cady 2006a                                      2
Cady 2006b                                      2
Cady 2009                                       2
Carpay 2004                                     3
Croop 2019                                      2
Cutler 1995                                     3
Dahlöf 1998                                     2
Dahlöf 2001                                     3
Dahlöf 2009                                     2
Diener 2002                                     3
Diener 2004                                     3
Diener 2005                                     2
Diener 2011                                     2
Dodick 2019                                     3
Dowson 2002a                                    3
Dowson 2002b                                    2
Eletriptan Steering Committee in Japan 2002     3
Ensink 1991                                     2
Färkkila 2003                                   3
Färkkila 2012                                   3
Freitag 2008                                    3
Garcia-Ramos 2003                               3
Geraud 2000                                     3
Gijsmant 1997                                   3
Goadsby 2000                                    4
Goadsby 2007                                    2
Goadsby 2008                                    2
Goadsby 2019                                    3
Göbel 2004                                      2
Goldstein 2006                                  2
Gomez-Mancilla 2014                             2
Gruffyd-Jones 2001                              3
Ho 2008a                                        2
Ho 2008b                                        2
Jelinski 2006                                   3
Kaniecki 2006                                   2
Kellstein 2000                                  3
Klapper 2004                                    2
Klassen 1997                                    3
Kramer 1998                                     2
Kuca 2018                                       3
Landy 2004                                      3
Lange 2000                                      2
Lines 2001                                      3
Lipton 2000                                     2
Lipton 2005                                     2
Lipton 2010                                     2
Lipton 2019a                                    2
Lipton 2019b                                    2
Lipton 2019c                                    2
Lipton 2021                                     2
Loder 2005                                      2
Marcus 2014                                     3
Massiou 2005                                    2
Mathew 2003                                     3
Mathew 2007                                     2
MOMENTUM 2019                                   2
Moon 2010                                       2
Munjal 2017                                     2
Myllylä 1998                                    2
Nappi 1994                                      2
NCT00920686 2010                                2
NCT01248468 2011                                2
NCT01657370 2012                                3
NCT01986270 / 104 1998                          3
NCT03235479 2018                                2
Nett 2003                                       3
Pascual 2000a                                   3
Pascual 2000b                                   3
Prior 2010                                      2
Rapoport 1997                                   3
Rapoport 2002                                   2
Ryan 2002a                                      2
Ryan 2002b                                      2
Ryan 2002c                                      3
S2WB3002 1996                                   4
Sakai 2002                                      3
Sakai 2021                                      3
Sandrini 2002                                   5
Saper 2006                                      2
Sargent 1995                                    3
Savani 1999                                     2
Sheftell 2003                                   3
Sheftell 2005a                                  3
Sheftell 2005b                                  3
Smith 2005                                      3
Solomon 1997                                    2
Spierings 2001                                  2
Stark 2002                                      3
Steiner 2003                                    4
SUM20033 2003                                   2
Tazaki 1993                                     2
Teall 1996                                      3
Tfelt-Hansen 1995                               2
Tfelt-Hansen 1998                               4
Tfelt-Hansen 2006                               2
Toledano 2021                                   2
Visser 1996a                                    3
Visser 1996b                                    2
Voss 2016                                       3
Wentz 2008                                      2
Winner 2003a                                    3
Winner 2003b                                    3
Yu 2023                                         2

Results (common effects model):

                                                            treat1              treat2     OR            95%-CI     Q leverage
0462-039 1996                                              placebo  rizatriptan (high) 0.2305 [0.2039;  0.2606]  0.54        .
0462-039 1996                                              placebo   rizatriptan (low) 0.3352 [0.2843;  0.3952]  0.34        .
0462-039 1996                                   rizatriptan (high)   rizatriptan (low) 1.4540 [1.2473;  1.6950]  0.02        .
103 UN                                            eletriptan (low)             placebo 4.6857 [4.1317;  5.3141]  0.34     0.02
Ahrens 1999                                                placebo  rizatriptan (high) 0.2305 [0.2039;  0.2606]  1.39        .
Ahrens 1999                                                placebo   rizatriptan (low) 0.3352 [0.2843;  0.3952]  1.61        .
Ahrens 1999                                     rizatriptan (high)   rizatriptan (low) 1.4540 [1.2473;  1.6950]  0.07        .
Ashina 2021                                      lasmiditan (high)    lasmiditan (low) 1.3400 [1.1798;  1.5220]  0.24        .
Ashina 2021                                      lasmiditan (high)             placebo 2.5536 [2.1799;  2.9914]  3.81        .
Ashina 2021                                       lasmiditan (low)             placebo 1.9056 [1.6359;  2.2198]  4.55        .
Barbanti 2012                                              placebo  rizatriptan (high) 0.2305 [0.2039;  0.2606]  2.30     0.01
Bomhof 1999                                     naratriptan (high)             placebo 1.8703 [1.5019;  2.3290]  0.52        .
Bomhof 1999                                     naratriptan (high)  rizatriptan (high) 0.4312 [0.3412;  0.5449]  1.69        .
Bomhof 1999                                                placebo  rizatriptan (high) 0.2305 [0.2039;  0.2606]  2.23        .
Brandes 2005                                      eletriptan (low)             placebo 4.6857 [4.1317;  5.3141] 11.90     0.10
Brandes 2007a                                naproxen sodium (low)             placebo 2.1743 [1.7486;  2.7036]  0.57        .
Brandes 2007a                                naproxen sodium (low)  sumatriptan (high) 0.5934 [0.4789;  0.7354]  0.35        .
Brandes 2007a                                              placebo  sumatriptan (high) 0.2729 [0.2506;  0.2972]  0.20        .
Brandes 2007b                                naproxen sodium (low)             placebo 2.1743 [1.7486;  2.7036]  0.94        .
Brandes 2007b                                naproxen sodium (low)  sumatriptan (high) 0.5934 [0.4789;  0.7354]  0.18        .
Brandes 2007b                                              placebo  sumatriptan (high) 0.2729 [0.2506;  0.2972]  2.17        .
Brauneis 1994                                              placebo  sumatriptan (high) 0.2729 [0.2506;  0.2972]  1.33     0.00
Bussone 2000                                               placebo   sumatriptan (low) 0.3200 [0.2899;  0.3533]  0.18     0.01
Cady 2006a                                                 placebo  rizatriptan (high) 0.2305 [0.2039;  0.2606]  5.96     0.11
Cady 2006b                                                 placebo  rizatriptan (high) 0.2305 [0.2039;  0.2606]  5.00     0.11
Cady 2009                                                  placebo  rizatriptan (high) 0.2305 [0.2039;  0.2606]  0.04     0.02
Carpay 2004                                                placebo  sumatriptan (high) 0.2729 [0.2506;  0.2972]  2.80        .
Carpay 2004                                                placebo   sumatriptan (low) 0.3200 [0.2899;  0.3533]  0.08        .
Carpay 2004                                     sumatriptan (high)   sumatriptan (low) 1.1726 [1.0631;  1.2933]  3.15        .
Croop 2019                                                 placebo          rimegepant 0.5252 [0.4515;  0.6109]  0.60     0.25
Cutler 1995                                                placebo  sumatriptan (high) 0.2729 [0.2506;  0.2972]  0.00        .
Cutler 1995                                                placebo   sumatriptan (low) 0.3200 [0.2899;  0.3533]  0.04        .
Cutler 1995                                     sumatriptan (high)   sumatriptan (low) 1.1726 [1.0631;  1.2933]  0.04        .
Dahlöf 1998                                                placebo zolmitriptan (high) 0.2724 [0.2336;  0.3176]  6.10     0.01
Dahlöf 2001                                     almotriptan (high)   almotriptan (low) 1.4542 [1.1442;  1.8483]  0.05        .
Dahlöf 2001                                     almotriptan (high)             placebo 2.5454 [2.1931;  2.9544]  1.61        .
Dahlöf 2001                                      almotriptan (low)             placebo 1.7504 [1.3401;  2.2864]  1.17        .
Dahlöf 2009                                                placebo   sumatriptan (low) 0.3200 [0.2899;  0.3533]  0.96     0.01
Diener 2002                                      eletriptan (high)    eletriptan (low) 1.4198 [1.2568;  1.6040]  0.13        .
Diener 2002                                      eletriptan (high)             placebo 6.6529 [5.7087;  7.7532]  0.81        .
Diener 2002                                       eletriptan (low)             placebo 4.6857 [4.1317;  5.3141]  0.51        .
Diener 2004                                   acetylsalicylic acid             placebo 2.5421 [1.8682;  3.4591]  0.41        .
Diener 2004                                   acetylsalicylic acid   sumatriptan (low) 0.8136 [0.5930;  1.1162]  0.58        .
Diener 2004                                                placebo   sumatriptan (low) 0.3200 [0.2899;  0.3533]  1.54        .
Diener 2005                                   diclofenac potassium             placebo 2.9738 [2.0423;  4.3301]  0.17     0.20
Diener 2011                                       eletriptan (low)             placebo 4.6857 [4.1317;  5.3141]  0.05     0.02
Dodick 2019                                                placebo   ubrogepant (high) 0.4865 [0.3641;  0.6501]  0.09        .
Dodick 2019                                                placebo    ubrogepant (low) 0.5579 [0.4394;  0.7083]  0.23        .
Dodick 2019                                      ubrogepant (high)    ubrogepant (low) 1.1467 [0.8784;  1.4970]  0.07        .
Dowson 2002a                                    almotriptan (high)             placebo 2.5454 [2.1931;  2.9544]  0.15        .
Dowson 2002a                                    almotriptan (high)  sumatriptan (high) 0.6947 [0.5935;  0.8133]  0.14        .
Dowson 2002a                                               placebo  sumatriptan (high) 0.2729 [0.2506;  0.2972]  0.40        .
Dowson 2002b                                               placebo  zolmitriptan (low) 0.3233 [0.2856;  0.3659]  0.73     0.05
Eletriptan Steering Committee in Japan 2002      eletriptan (high)    eletriptan (low) 1.4198 [1.2568;  1.6040]  0.07        .
Eletriptan Steering Committee in Japan 2002      eletriptan (high)             placebo 6.6529 [5.7087;  7.7532]  1.98        .
Eletriptan Steering Committee in Japan 2002       eletriptan (low)             placebo 4.6857 [4.1317;  5.3141]  2.88        .
Ensink 1991                                                placebo  sumatriptan (high) 0.2729 [0.2506;  0.2972]  1.31     0.01
Färkkila 2003                                    eletriptan (high)    eletriptan (low) 1.4198 [1.2568;  1.6040]  0.04        .
Färkkila 2003                                    eletriptan (high)             placebo 6.6529 [5.7087;  7.7532]  0.34        .
Färkkila 2003                                     eletriptan (low)             placebo 4.6857 [4.1317;  5.3141]  0.26        .
Färkkila 2012                                    lasmiditan (high)    lasmiditan (low) 1.3400 [1.1798;  1.5220]  0.01        .
Färkkila 2012                                    lasmiditan (high)             placebo 2.5536 [2.1799;  2.9914]  0.01        .
Färkkila 2012                                     lasmiditan (low)             placebo 1.9056 [1.6359;  2.2198]  0.00        .
Freitag 2008                                    paracetamol (high)             placebo 2.1031 [1.3969;  3.1662]  0.00        .
Freitag 2008                                    paracetamol (high)  rizatriptan (high) 0.4848 [0.3181;  0.7389]  0.05        .
Freitag 2008                                               placebo  rizatriptan (high) 0.2305 [0.2039;  0.2606]  0.02        .
Garcia-Ramos 2003                                 eletriptan (low)  naratriptan (high) 2.5053 [1.9791;  3.1716]  0.66        .
Garcia-Ramos 2003                                 eletriptan (low)             placebo 4.6857 [4.1317;  5.3141]  3.34        .
Garcia-Ramos 2003                               naratriptan (high)             placebo 1.8703 [1.5019;  2.3290]  1.13        .
Geraud 2000                                                placebo  sumatriptan (high) 0.2729 [0.2506;  0.2972]  0.11        .
Geraud 2000                                                placebo zolmitriptan (high) 0.2724 [0.2336;  0.3176]  0.16        .
Geraud 2000                                     sumatriptan (high) zolmitriptan (high) 0.9980 [0.8561;  1.1634]  0.07        .
Gijsmant 1997                                              placebo  rizatriptan (high) 0.2305 [0.2039;  0.2606]  1.18        .
Gijsmant 1997                                              placebo   rizatriptan (low) 0.3352 [0.2843;  0.3952]  0.89        .
Gijsmant 1997                                   rizatriptan (high)   rizatriptan (low) 1.4540 [1.2473;  1.6950]  0.01        .
Goadsby 2000                                     eletriptan (high)    eletriptan (low) 1.4198 [1.2568;  1.6040]  0.26        .
Goadsby 2000                                     eletriptan (high)             placebo 6.6529 [5.7087;  7.7532]  0.06        .
Goadsby 2000                                     eletriptan (high)  sumatriptan (high) 1.8158 [1.5555;  2.1196]  0.17        .
Goadsby 2000                                      eletriptan (low)             placebo 4.6857 [4.1317;  5.3141]  0.00        .
Goadsby 2000                                      eletriptan (low)  sumatriptan (high) 1.2789 [1.1276;  1.4505]  0.88        .
Goadsby 2000                                               placebo  sumatriptan (high) 0.2729 [0.2506;  0.2972]  0.15        .
Goadsby 2007                                    almotriptan (high)  zolmitriptan (low) 0.8229 [0.7016;  0.9651]  0.00     0.44
Goadsby 2008                                    almotriptan (high)             placebo 2.5454 [2.1931;  2.9544]  0.39     0.12
Goadsby 2019                                     lasmiditan (high)    lasmiditan (low) 1.3400 [1.1798;  1.5220]  0.02        .
Goadsby 2019                                     lasmiditan (high)             placebo 2.5536 [2.1799;  2.9914]  1.22        .
Goadsby 2019                                      lasmiditan (low)             placebo 1.9056 [1.6359;  2.2198]  2.38        .
Göbel 2004                                               phenazone             placebo 2.4129 [1.2022;  4.8426]  0.00     1.00
Goldstein 2006                                    ibuprofen (high)             placebo 1.8641 [1.4262;  2.4364]  4.59     0.59
Gomez-Mancilla 2014                                        placebo  sumatriptan (high) 0.2729 [0.2506;  0.2972]  1.22     0.00
Gruffyd-Jones 2001                               sumatriptan (low) zolmitriptan (high) 0.8511 [0.7276;  0.9956]  0.81        .
Gruffyd-Jones 2001                               sumatriptan (low)  zolmitriptan (low) 1.0101 [0.8826;  1.1561]  1.38        .
Gruffyd-Jones 2001                             zolmitriptan (high)  zolmitriptan (low) 1.1868 [1.0125;  1.3911]  0.10        .
Ho 2008a                                                   placebo  rizatriptan (high) 0.2305 [0.2039;  0.2606]  1.28     0.02
Ho 2008b                                                   placebo zolmitriptan (high) 0.2724 [0.2336;  0.3176]  0.23     0.12
Jelinski 2006                                              placebo  sumatriptan (high) 0.2729 [0.2506;  0.2972]  0.94        .
Jelinski 2006                                              placebo   sumatriptan (low) 0.3200 [0.2899;  0.3533]  0.20        .
Jelinski 2006                                   sumatriptan (high)   sumatriptan (low) 1.1726 [1.0631;  1.2933]  0.56        .
Kaniecki 2006                                              placebo  sumatriptan (high) 0.2729 [0.2506;  0.2972]  4.21     0.02
Kellstein 2000                                    ibuprofen (high)     ibuprofen (low) 1.0697 [0.7417;  1.5428]  0.06        .
Kellstein 2000                                    ibuprofen (high)             placebo 1.8641 [1.4262;  2.4364]  0.93        .
Kellstein 2000                                     ibuprofen (low)             placebo 1.7426 [1.1371;  2.6705]  0.30        .
Klapper 2004                                               placebo  zolmitriptan (low) 0.3233 [0.2856;  0.3659]  0.00     0.05
Klassen 1997                                    naratriptan (high)   naratriptan (low) 1.9150 [1.2768;  2.8722]  0.02        .
Klassen 1997                                    naratriptan (high)             placebo 1.8703 [1.5019;  2.3290]  0.04        .
Klassen 1997                                     naratriptan (low)             placebo 0.9767 [0.6532;  1.4603]  0.00        .
Kramer 1998                                                placebo  rizatriptan (high) 0.2305 [0.2039;  0.2606]  2.75     0.02
Kuca 2018                                        lasmiditan (high)    lasmiditan (low) 1.3400 [1.1798;  1.5220]  0.38        .
Kuca 2018                                        lasmiditan (high)             placebo 2.5536 [2.1799;  2.9914]  0.13        .
Kuca 2018                                         lasmiditan (low)             placebo 1.9056 [1.6359;  2.2198]  0.01        .
Landy 2004                                                 placebo  sumatriptan (high) 0.2729 [0.2506;  0.2972]  0.49        .
Landy 2004                                                 placebo   sumatriptan (low) 0.3200 [0.2899;  0.3533]  0.21        .
Landy 2004                                      sumatriptan (high)   sumatriptan (low) 1.1726 [1.0631;  1.2933]  0.09        .
Lange 2000                                    acetylsalicylic acid             placebo 2.5421 [1.8682;  3.4591]  0.69     0.35
Lines 2001                                                 placebo   rizatriptan (low) 0.3352 [0.2843;  0.3952]  1.86        .
Lines 2001                                                 placebo   sumatriptan (low) 0.3200 [0.2899;  0.3533]  2.58        .
Lines 2001                                       rizatriptan (low)   sumatriptan (low) 0.9547 [0.8031;  1.1351]  0.89        .
Lipton 2000                                     paracetamol (high)             placebo 2.1031 [1.3969;  3.1662]  0.07     0.41
Lipton 2005                                   acetylsalicylic acid             placebo 2.5421 [1.8682;  3.4591]  0.66     0.23
Lipton 2010                                   diclofenac potassium             placebo 2.9738 [2.0423;  4.3301]  0.04     0.80
Lipton 2019a                                             celecoxib             placebo 1.7619 [1.3630;  2.2775]  0.63     0.47
Lipton 2019b                                               placebo    ubrogepant (low) 0.5579 [0.4394;  0.7083]  0.00     0.47
Lipton 2019c                                               placebo          rimegepant 0.5252 [0.4515;  0.6109]  0.18     0.20
Lipton 2021                                              celecoxib             placebo 1.7619 [1.3630;  2.2775]  1.01     0.51
Loder 2005                                                 placebo  zolmitriptan (low) 0.3233 [0.2856;  0.3659]  0.72     0.11
Marcus 2014                                                placebo          rimegepant 0.5252 [0.4515;  0.6109]  0.88        .
Marcus 2014                                                placebo  sumatriptan (high) 0.2729 [0.2506;  0.2972]  0.34        .
Marcus 2014                                             rimegepant  sumatriptan (high) 0.5197 [0.4376;  0.6172]  1.89        .
Massiou 2005                                    naratriptan (high)             placebo 1.8703 [1.5019;  2.3290]  0.41     0.16
Mathew 2003                                       eletriptan (low)             placebo 4.6857 [4.1317;  5.3141]  4.67        .
Mathew 2003                                       eletriptan (low)  sumatriptan (high) 1.2789 [1.1276;  1.4505]  2.01        .
Mathew 2003                                                placebo  sumatriptan (high) 0.2729 [0.2506;  0.2972]  2.31        .
Mathew 2007                                     almotriptan (high)             placebo 2.5454 [2.1931;  2.9544]  1.42     0.10
MOMENTUM 2019                                              placebo  rizatriptan (high) 0.2305 [0.2039;  0.2606]  1.73     0.04
Moon 2010                                             frovatriptan             placebo 2.7680 [2.0505;  3.7364]  0.91     0.10
Munjal 2017                                              celecoxib             placebo 1.7619 [1.3630;  2.2775]  1.28     0.02
Myllylä 1998                                               placebo  sumatriptan (high) 0.2729 [0.2506;  0.2972]  3.44     0.00
Nappi 1994                                                 placebo  sumatriptan (high) 0.2729 [0.2506;  0.2972]  2.17     0.01
NCT00920686 2010                                           placebo  sumatriptan (high) 0.2729 [0.2506;  0.2972]  7.23     0.01
NCT01248468 2011                                           placebo  sumatriptan (high) 0.2729 [0.2506;  0.2972]  4.63     0.04
NCT01657370 2012                                           placebo   ubrogepant (high) 0.4865 [0.3641;  0.6501]  0.29        .
NCT01657370 2012                                           placebo    ubrogepant (low) 0.5579 [0.4394;  0.7083]  1.95        .
NCT01657370 2012                                 ubrogepant (high)    ubrogepant (low) 1.1467 [0.8784;  1.4970]  2.40        .
NCT01986270 / 104 1998                           eletriptan (high)    eletriptan (low) 1.4198 [1.2568;  1.6040]  0.02        .
NCT01986270 / 104 1998                           eletriptan (high)             placebo 6.6529 [5.7087;  7.7532]  1.43        .
NCT01986270 / 104 1998                            eletriptan (low)             placebo 4.6857 [4.1317;  5.3141]  1.31        .
NCT03235479 2018                                           placebo          rimegepant 0.5252 [0.4515;  0.6109]  3.21     0.22
Nett 2003                                                  placebo  sumatriptan (high) 0.2729 [0.2506;  0.2972]  1.42        .
Nett 2003                                                  placebo   sumatriptan (low) 0.3200 [0.2899;  0.3533]  1.28        .
Nett 2003                                       sumatriptan (high)   sumatriptan (low) 1.1726 [1.0631;  1.2933]  0.01        .
Pascual 2000a                                   almotriptan (high)   almotriptan (low) 1.4542 [1.1442;  1.8483]  0.30        .
Pascual 2000a                                   almotriptan (high)             placebo 2.5454 [2.1931;  2.9544]  1.25        .
Pascual 2000a                                    almotriptan (low)             placebo 1.7504 [1.3401;  2.2864]  0.55        .
Pascual 2000b                                              placebo  rizatriptan (high) 0.2305 [0.2039;  0.2606]  1.33        .
Pascual 2000b                                              placebo  zolmitriptan (low) 0.3233 [0.2856;  0.3659]  1.42        .
Pascual 2000b                                   rizatriptan (high)  zolmitriptan (low) 1.4023 [1.1969;  1.6428]  0.05        .
Prior 2010                                      paracetamol (high)             placebo 2.1031 [1.3969;  3.1662]  0.20     0.35
Rapoport 1997                                              placebo zolmitriptan (high) 0.2724 [0.2336;  0.3176]  1.13        .
Rapoport 1997                                              placebo  zolmitriptan (low) 0.3233 [0.2856;  0.3659]  0.89        .
Rapoport 1997                                  zolmitriptan (high)  zolmitriptan (low) 1.1868 [1.0125;  1.3911]  0.04        .
Rapoport 2002                                         frovatriptan             placebo 2.7680 [2.0505;  3.7364]  1.47     0.11
Ryan 2002a                                            frovatriptan             placebo 2.7680 [2.0505;  3.7364]  1.56     0.04
Ryan 2002b                                            frovatriptan             placebo 2.7680 [2.0505;  3.7364]  3.39     0.19
Ryan 2002c                                            frovatriptan             placebo 2.7680 [2.0505;  3.7364]  0.01        .
Ryan 2002c                                            frovatriptan  sumatriptan (high) 0.7555 [0.5599;  1.0194]  6.08        .
Ryan 2002c                                                 placebo  sumatriptan (high) 0.2729 [0.2506;  0.2972]  1.48        .
S2WB3002 1996                                   naratriptan (high)   naratriptan (low) 1.9150 [1.2768;  2.8722]  0.03        .
S2WB3002 1996                                   naratriptan (high)             placebo 1.8703 [1.5019;  2.3290]  1.41        .
S2WB3002 1996                                   naratriptan (high)  sumatriptan (high) 0.5105 [0.4086;  0.6377]  0.00        .
S2WB3002 1996                                    naratriptan (low)             placebo 0.9767 [0.6532;  1.4603]  0.75        .
S2WB3002 1996                                    naratriptan (low)  sumatriptan (high) 0.2666 [0.1785;  0.3981]  0.04        .
S2WB3002 1996                                              placebo  sumatriptan (high) 0.2729 [0.2506;  0.2972]  2.15        .
Sakai 2002                                                 placebo zolmitriptan (high) 0.2724 [0.2336;  0.3176]  0.78        .
Sakai 2002                                                 placebo  zolmitriptan (low) 0.3233 [0.2856;  0.3659]  1.08        .
Sakai 2002                                     zolmitriptan (high)  zolmitriptan (low) 1.1868 [1.0125;  1.3911]  0.07        .
Sakai 2021                                       lasmiditan (high)    lasmiditan (low) 1.3400 [1.1798;  1.5220]  0.89        .
Sakai 2021                                       lasmiditan (high)             placebo 2.5536 [2.1799;  2.9914]  0.53        .
Sakai 2021                                        lasmiditan (low)             placebo 1.9056 [1.6359;  2.2198]  0.01        .
Sandrini 2002                                    eletriptan (high)    eletriptan (low) 1.4198 [1.2568;  1.6040]  0.05        .
Sandrini 2002                                    eletriptan (high)             placebo 6.6529 [5.7087;  7.7532]  0.58        .
Sandrini 2002                                    eletriptan (high)  sumatriptan (high) 1.8158 [1.5555;  2.1196]  1.18        .
Sandrini 2002                                    eletriptan (high)   sumatriptan (low) 2.1292 [1.8025;  2.5149]  0.23        .
Sandrini 2002                                     eletriptan (low)             placebo 4.6857 [4.1317;  5.3141]  0.65        .
Sandrini 2002                                     eletriptan (low)  sumatriptan (high) 1.2789 [1.1276;  1.4505]  1.54        .
Sandrini 2002                                     eletriptan (low)   sumatriptan (low) 1.4996 [1.3000;  1.7298]  0.42        .
Sandrini 2002                                              placebo  sumatriptan (high) 0.2729 [0.2506;  0.2972]  0.09        .
Sandrini 2002                                              placebo   sumatriptan (low) 0.3200 [0.2899;  0.3533]  0.26        .
Sandrini 2002                                   sumatriptan (high)   sumatriptan (low) 1.1726 [1.0631;  1.2933]  0.29        .
Saper 2006                                        ibuprofen (high)             placebo 1.8641 [1.4262;  2.4364]  7.94     0.14
Sargent 1995                                               placebo  sumatriptan (high) 0.2729 [0.2506;  0.2972]  0.05        .
Sargent 1995                                               placebo   sumatriptan (low) 0.3200 [0.2899;  0.3533]  0.02        .
Sargent 1995                                    sumatriptan (high)   sumatriptan (low) 1.1726 [1.0631;  1.2933]  0.07        .
Savani 1999                                                placebo   sumatriptan (low) 0.3200 [0.2899;  0.3533]  2.40     0.01
Sheftell 2003                                    eletriptan (high)    eletriptan (low) 1.4198 [1.2568;  1.6040]  0.00        .
Sheftell 2003                                    eletriptan (high)             placebo 6.6529 [5.7087;  7.7532]  0.31        .
Sheftell 2003                                     eletriptan (low)             placebo 4.6857 [4.1317;  5.3141]  0.48        .
Sheftell 2005a                                             placebo  sumatriptan (high) 0.2729 [0.2506;  0.2972]  0.01        .
Sheftell 2005a                                             placebo   sumatriptan (low) 0.3200 [0.2899;  0.3533]  0.57        .
Sheftell 2005a                                  sumatriptan (high)   sumatriptan (low) 1.1726 [1.0631;  1.2933]  1.29        .
Sheftell 2005b                                             placebo  sumatriptan (high) 0.2729 [0.2506;  0.2972]  4.40        .
Sheftell 2005b                                             placebo   sumatriptan (low) 0.3200 [0.2899;  0.3533]  2.29        .
Sheftell 2005b                                  sumatriptan (high)   sumatriptan (low) 1.1726 [1.0631;  1.2933]  0.73        .
Smith 2005                                   naproxen sodium (low)             placebo 2.1743 [1.7486;  2.7036]  1.07        .
Smith 2005                                   naproxen sodium (low)   sumatriptan (low) 0.6959 [0.5565;  0.8702]  0.99        .
Smith 2005                                                 placebo   sumatriptan (low) 0.3200 [0.2899;  0.3533]  0.17        .
Solomon 1997                                               placebo  zolmitriptan (low) 0.3233 [0.2856;  0.3659]  0.56     0.03
Spierings 2001                                  almotriptan (high)   sumatriptan (low) 0.8146 [0.6970;  0.9521]  1.69     0.31
Stark 2002                                       eletriptan (high)    eletriptan (low) 1.4198 [1.2568;  1.6040]  2.06        .
Stark 2002                                       eletriptan (high)             placebo 6.6529 [5.7087;  7.7532]  3.29        .
Stark 2002                                        eletriptan (low)             placebo 4.6857 [4.1317;  5.3141]  4.37        .
Steiner 2003                                     eletriptan (high)    eletriptan (low) 1.4198 [1.2568;  1.6040]  0.24        .
Steiner 2003                                     eletriptan (high)             placebo 6.6529 [5.7087;  7.7532]  0.39        .
Steiner 2003                                     eletriptan (high)  zolmitriptan (low) 2.1507 [1.8105;  2.5549]  0.45        .
Steiner 2003                                      eletriptan (low)             placebo 4.6857 [4.1317;  5.3141]  0.19        .
Steiner 2003                                      eletriptan (low)  zolmitriptan (low) 1.5148 [1.2984;  1.7673]  1.07        .
Steiner 2003                                               placebo  zolmitriptan (low) 0.3233 [0.2856;  0.3659]  0.52        .
SUM20033 2003                                              placebo  sumatriptan (high) 0.2729 [0.2506;  0.2972]  0.69     0.02
Tazaki 1993                                                placebo  sumatriptan (high) 0.2729 [0.2506;  0.2972]  1.11     0.01
Teall 1996                                                 placebo  rizatriptan (high) 0.2305 [0.2039;  0.2606]  1.60        .
Teall 1996                                                 placebo   rizatriptan (low) 0.3352 [0.2843;  0.3952]  1.36        .
Teall 1996                                      rizatriptan (high)   rizatriptan (low) 1.4540 [1.2473;  1.6950]  0.00        .
Tfelt-Hansen 1995                                          placebo  sumatriptan (high) 0.2729 [0.2506;  0.2972]  0.25     0.01
Tfelt-Hansen 1998                                          placebo  rizatriptan (high) 0.2305 [0.2039;  0.2606]  0.39        .
Tfelt-Hansen 1998                                          placebo   rizatriptan (low) 0.3352 [0.2843;  0.3952]  0.01        .
Tfelt-Hansen 1998                                          placebo  sumatriptan (high) 0.2729 [0.2506;  0.2972]  0.10        .
Tfelt-Hansen 1998                               rizatriptan (high)   rizatriptan (low) 1.4540 [1.2473;  1.6950]  0.47        .
Tfelt-Hansen 1998                               rizatriptan (high)  sumatriptan (high) 1.1839 [1.0353;  1.3538]  0.56        .
Tfelt-Hansen 1998                                rizatriptan (low)  sumatriptan (high) 0.8142 [0.6861;  0.9663]  0.05        .
Tfelt-Hansen 2006                                          placebo   sumatriptan (low) 0.3200 [0.2899;  0.3533]  0.02     0.01
Toledano 2021                                    paracetamol (low)             placebo 1.6000 [0.4144;  6.1769]  0.00     1.00
Visser 1996a                                               placebo  rizatriptan (high) 0.2305 [0.2039;  0.2606]  0.94        .
Visser 1996a                                               placebo  sumatriptan (high) 0.2729 [0.2506;  0.2972]  0.64        .
Visser 1996a                                    rizatriptan (high)  sumatriptan (high) 1.1839 [1.0353;  1.3538]  0.01        .
Visser 1996b                                               placebo zolmitriptan (high) 0.2724 [0.2336;  0.3176]  0.02     0.00
Voss 2016                                                  placebo   ubrogepant (high) 0.4865 [0.3641;  0.6501]  0.52        .
Voss 2016                                                  placebo    ubrogepant (low) 0.5579 [0.4394;  0.7083]  0.32        .
Voss 2016                                        ubrogepant (high)    ubrogepant (low) 1.1467 [0.8784;  1.4970]  0.03        .
Wentz 2008                                  naproxen sodium (high)             placebo 5.4321 [2.2610; 13.0510]  0.00     1.00
Winner 2003a                                               placebo  sumatriptan (high) 0.2729 [0.2506;  0.2972]  1.39        .
Winner 2003a                                               placebo   sumatriptan (low) 0.3200 [0.2899;  0.3533]  0.92        .
Winner 2003a                                    sumatriptan (high)   sumatriptan (low) 1.1726 [1.0631;  1.2933]  0.06        .
Winner 2003b                                               placebo  sumatriptan (high) 0.2729 [0.2506;  0.2972]  0.34        .
Winner 2003b                                               placebo   sumatriptan (low) 0.3200 [0.2899;  0.3533]  0.27        .
Winner 2003b                                    sumatriptan (high)   sumatriptan (low) 1.1726 [1.0631;  1.2933]  0.00        .
Yu 2023                                                    placebo          rimegepant 0.5252 [0.4515;  0.6109]  0.14     0.24

Results (random effects model):

                                                            treat1              treat2     OR            95%-CI
0462-039 1996                                              placebo  rizatriptan (high) 0.2216 [0.1869;  0.2628]
0462-039 1996                                              placebo   rizatriptan (low) 0.3169 [0.2500;  0.4017]
0462-039 1996                                   rizatriptan (high)   rizatriptan (low) 1.4299 [1.1337;  1.8035]
103 UN                                            eletriptan (low)             placebo 4.7134 [3.9351;  5.6456]
Ahrens 1999                                                placebo  rizatriptan (high) 0.2216 [0.1869;  0.2628]
Ahrens 1999                                                placebo   rizatriptan (low) 0.3169 [0.2500;  0.4017]
Ahrens 1999                                     rizatriptan (high)   rizatriptan (low) 1.4299 [1.1337;  1.8035]
Ashina 2021                                      lasmiditan (high)    lasmiditan (low) 1.3411 [1.0580;  1.7000]
Ashina 2021                                      lasmiditan (high)             placebo 2.7119 [2.0936;  3.5130]
Ashina 2021                                       lasmiditan (low)             placebo 2.0221 [1.5664;  2.6105]
Barbanti 2012                                              placebo  rizatriptan (high) 0.2216 [0.1869;  0.2628]
Bomhof 1999                                     naratriptan (high)             placebo 1.9248 [1.4489;  2.5570]
Bomhof 1999                                     naratriptan (high)  rizatriptan (high) 0.4266 [0.3124;  0.5826]
Bomhof 1999                                                placebo  rizatriptan (high) 0.2216 [0.1869;  0.2628]
Brandes 2005                                      eletriptan (low)             placebo 4.7134 [3.9351;  5.6456]
Brandes 2007a                                naproxen sodium (low)             placebo 2.1927 [1.6172;  2.9730]
Brandes 2007a                                naproxen sodium (low)  sumatriptan (high) 0.5932 [0.4375;  0.8042]
Brandes 2007a                                              placebo  sumatriptan (high) 0.2705 [0.2406;  0.3042]
Brandes 2007b                                naproxen sodium (low)             placebo 2.1927 [1.6172;  2.9730]
Brandes 2007b                                naproxen sodium (low)  sumatriptan (high) 0.5932 [0.4375;  0.8042]
Brandes 2007b                                              placebo  sumatriptan (high) 0.2705 [0.2406;  0.3042]
Brauneis 1994                                              placebo  sumatriptan (high) 0.2705 [0.2406;  0.3042]
Bussone 2000                                               placebo   sumatriptan (low) 0.3163 [0.2748;  0.3641]
Cady 2006a                                                 placebo  rizatriptan (high) 0.2216 [0.1869;  0.2628]
Cady 2006b                                                 placebo  rizatriptan (high) 0.2216 [0.1869;  0.2628]
Cady 2009                                                  placebo  rizatriptan (high) 0.2216 [0.1869;  0.2628]
Carpay 2004                                                placebo  sumatriptan (high) 0.2705 [0.2406;  0.3042]
Carpay 2004                                                placebo   sumatriptan (low) 0.3163 [0.2748;  0.3641]
Carpay 2004                                     sumatriptan (high)   sumatriptan (low) 1.1692 [1.0082;  1.3560]
Croop 2019                                                 placebo          rimegepant 0.5120 [0.4027;  0.6508]
Cutler 1995                                                placebo  sumatriptan (high) 0.2705 [0.2406;  0.3042]
Cutler 1995                                                placebo   sumatriptan (low) 0.3163 [0.2748;  0.3641]
Cutler 1995                                     sumatriptan (high)   sumatriptan (low) 1.1692 [1.0082;  1.3560]
Dahlöf 1998                                                placebo zolmitriptan (high) 0.2585 [0.2021;  0.3307]
Dahlöf 2001                                     almotriptan (high)   almotriptan (low) 1.3962 [0.9681;  2.0137]
Dahlöf 2001                                     almotriptan (high)             placebo 2.6575 [2.1239;  3.3251]
Dahlöf 2001                                      almotriptan (low)             placebo 1.9033 [1.2847;  2.8199]
Dahlöf 2009                                                placebo   sumatriptan (low) 0.3163 [0.2748;  0.3641]
Diener 2002                                      eletriptan (high)    eletriptan (low) 1.4620 [1.2146;  1.7597]
Diener 2002                                      eletriptan (high)             placebo 6.8908 [5.5576;  8.5440]
Diener 2002                                       eletriptan (low)             placebo 4.7134 [3.9351;  5.6456]
Diener 2004                                   acetylsalicylic acid             placebo 2.5609 [1.7460;  3.7562]
Diener 2004                                   acetylsalicylic acid   sumatriptan (low) 0.8101 [0.5447;  1.2048]
Diener 2004                                                placebo   sumatriptan (low) 0.3163 [0.2748;  0.3641]
Diener 2005                                   diclofenac potassium             placebo 3.0289 [1.8428;  4.9783]
Diener 2011                                       eletriptan (low)             placebo 4.7134 [3.9351;  5.6456]
Dodick 2019                                                placebo   ubrogepant (high) 0.4794 [0.3154;  0.7284]
Dodick 2019                                                placebo    ubrogepant (low) 0.5312 [0.3748;  0.7529]
Dodick 2019                                      ubrogepant (high)    ubrogepant (low) 1.1081 [0.7496;  1.6382]
Dowson 2002a                                    almotriptan (high)             placebo 2.6575 [2.1239;  3.3251]
Dowson 2002a                                    almotriptan (high)  sumatriptan (high) 0.7189 [0.5654;  0.9142]
Dowson 2002a                                               placebo  sumatriptan (high) 0.2705 [0.2406;  0.3042]
Dowson 2002b                                               placebo  zolmitriptan (low) 0.3113 [0.2580;  0.3757]
Eletriptan Steering Committee in Japan 2002      eletriptan (high)    eletriptan (low) 1.4620 [1.2146;  1.7597]
Eletriptan Steering Committee in Japan 2002      eletriptan (high)             placebo 6.8908 [5.5576;  8.5440]
Eletriptan Steering Committee in Japan 2002       eletriptan (low)             placebo 4.7134 [3.9351;  5.6456]
Ensink 1991                                                placebo  sumatriptan (high) 0.2705 [0.2406;  0.3042]
Färkkila 2003                                    eletriptan (high)    eletriptan (low) 1.4620 [1.2146;  1.7597]
Färkkila 2003                                    eletriptan (high)             placebo 6.8908 [5.5576;  8.5440]
Färkkila 2003                                     eletriptan (low)             placebo 4.7134 [3.9351;  5.6456]
Färkkila 2012                                    lasmiditan (high)    lasmiditan (low) 1.3411 [1.0580;  1.7000]
Färkkila 2012                                    lasmiditan (high)             placebo 2.7119 [2.0936;  3.5130]
Färkkila 2012                                     lasmiditan (low)             placebo 2.0221 [1.5664;  2.6105]
Freitag 2008                                    paracetamol (high)             placebo 2.1186 [1.3210;  3.3979]
Freitag 2008                                    paracetamol (high)  rizatriptan (high) 0.4696 [0.2871;  0.7679]
Freitag 2008                                               placebo  rizatriptan (high) 0.2216 [0.1869;  0.2628]
Garcia-Ramos 2003                                 eletriptan (low)  naratriptan (high) 2.4487 [1.7844;  3.3604]
Garcia-Ramos 2003                                 eletriptan (low)             placebo 4.7134 [3.9351;  5.6456]
Garcia-Ramos 2003                               naratriptan (high)             placebo 1.9248 [1.4489;  2.5570]
Geraud 2000                                                placebo  sumatriptan (high) 0.2705 [0.2406;  0.3042]
Geraud 2000                                                placebo zolmitriptan (high) 0.2585 [0.2021;  0.3307]
Geraud 2000                                     sumatriptan (high) zolmitriptan (high) 0.9556 [0.7408;  1.2327]
Gijsmant 1997                                              placebo  rizatriptan (high) 0.2216 [0.1869;  0.2628]
Gijsmant 1997                                              placebo   rizatriptan (low) 0.3169 [0.2500;  0.4017]
Gijsmant 1997                                   rizatriptan (high)   rizatriptan (low) 1.4299 [1.1337;  1.8035]
Goadsby 2000                                     eletriptan (high)    eletriptan (low) 1.4620 [1.2146;  1.7597]
Goadsby 2000                                     eletriptan (high)             placebo 6.8908 [5.5576;  8.5440]
Goadsby 2000                                     eletriptan (high)  sumatriptan (high) 1.8642 [1.4857;  2.3391]
Goadsby 2000                                      eletriptan (low)             placebo 4.7134 [3.9351;  5.6456]
Goadsby 2000                                      eletriptan (low)  sumatriptan (high) 1.2751 [1.0501;  1.5483]
Goadsby 2000                                               placebo  sumatriptan (high) 0.2705 [0.2406;  0.3042]
Goadsby 2007                                    almotriptan (high)  zolmitriptan (low) 0.8274 [0.6366;  1.0752]
Goadsby 2008                                    almotriptan (high)             placebo 2.6575 [2.1239;  3.3251]
Goadsby 2019                                     lasmiditan (high)    lasmiditan (low) 1.3411 [1.0580;  1.7000]
Goadsby 2019                                     lasmiditan (high)             placebo 2.7119 [2.0936;  3.5130]
Goadsby 2019                                      lasmiditan (low)             placebo 2.0221 [1.5664;  2.6105]
Göbel 2004                                               phenazone             placebo 2.4129 [1.0751;  5.4155]
Goldstein 2006                                    ibuprofen (high)             placebo 2.1077 [1.4530;  3.0573]
Gomez-Mancilla 2014                                        placebo  sumatriptan (high) 0.2705 [0.2406;  0.3042]
Gruffyd-Jones 2001                               sumatriptan (low) zolmitriptan (high) 0.8173 [0.6289;  1.0621]
Gruffyd-Jones 2001                               sumatriptan (low)  zolmitriptan (low) 0.9842 [0.7931;  1.2214]
Gruffyd-Jones 2001                             zolmitriptan (high)  zolmitriptan (low) 1.2042 [0.9269;  1.5646]
Ho 2008a                                                   placebo  rizatriptan (high) 0.2216 [0.1869;  0.2628]
Ho 2008b                                                   placebo zolmitriptan (high) 0.2585 [0.2021;  0.3307]
Jelinski 2006                                              placebo  sumatriptan (high) 0.2705 [0.2406;  0.3042]
Jelinski 2006                                              placebo   sumatriptan (low) 0.3163 [0.2748;  0.3641]
Jelinski 2006                                   sumatriptan (high)   sumatriptan (low) 1.1692 [1.0082;  1.3560]
Kaniecki 2006                                              placebo  sumatriptan (high) 0.2705 [0.2406;  0.3042]
Kellstein 2000                                    ibuprofen (high)     ibuprofen (low) 1.0669 [0.6273;  1.8144]
Kellstein 2000                                    ibuprofen (high)             placebo 2.1077 [1.4530;  3.0573]
Kellstein 2000                                     ibuprofen (low)             placebo 1.9755 [1.1036;  3.5364]
Klapper 2004                                               placebo  zolmitriptan (low) 0.3113 [0.2580;  0.3757]
Klassen 1997                                    naratriptan (high)   naratriptan (low) 1.8930 [1.1607;  3.0872]
Klassen 1997                                    naratriptan (high)             placebo 1.9248 [1.4489;  2.5570]
Klassen 1997                                     naratriptan (low)             placebo 1.0168 [0.6249;  1.6544]
Kramer 1998                                                placebo  rizatriptan (high) 0.2216 [0.1869;  0.2628]
Kuca 2018                                        lasmiditan (high)    lasmiditan (low) 1.3411 [1.0580;  1.7000]
Kuca 2018                                        lasmiditan (high)             placebo 2.7119 [2.0936;  3.5130]
Kuca 2018                                         lasmiditan (low)             placebo 2.0221 [1.5664;  2.6105]
Landy 2004                                                 placebo  sumatriptan (high) 0.2705 [0.2406;  0.3042]
Landy 2004                                                 placebo   sumatriptan (low) 0.3163 [0.2748;  0.3641]
Landy 2004                                      sumatriptan (high)   sumatriptan (low) 1.1692 [1.0082;  1.3560]
Lange 2000                                    acetylsalicylic acid             placebo 2.5609 [1.7460;  3.7562]
Lines 2001                                                 placebo   rizatriptan (low) 0.3169 [0.2500;  0.4017]
Lines 2001                                                 placebo   sumatriptan (low) 0.3163 [0.2748;  0.3641]
Lines 2001                                       rizatriptan (low)   sumatriptan (low) 0.9981 [0.7720;  1.2903]
Lipton 2000                                     paracetamol (high)             placebo 2.1186 [1.3210;  3.3979]
Lipton 2005                                   acetylsalicylic acid             placebo 2.5609 [1.7460;  3.7562]
Lipton 2010                                   diclofenac potassium             placebo 3.0289 [1.8428;  4.9783]
Lipton 2019a                                             celecoxib             placebo 1.8111 [1.2383;  2.6489]
Lipton 2019b                                               placebo    ubrogepant (low) 0.5312 [0.3748;  0.7529]
Lipton 2019c                                               placebo          rimegepant 0.5120 [0.4027;  0.6508]
Lipton 2021                                              celecoxib             placebo 1.8111 [1.2383;  2.6489]
Loder 2005                                                 placebo  zolmitriptan (low) 0.3113 [0.2580;  0.3757]
Marcus 2014                                                placebo          rimegepant 0.5120 [0.4027;  0.6508]
Marcus 2014                                                placebo  sumatriptan (high) 0.2705 [0.2406;  0.3042]
Marcus 2014                                             rimegepant  sumatriptan (high) 0.5284 [0.4060;  0.6877]
Massiou 2005                                    naratriptan (high)             placebo 1.9248 [1.4489;  2.5570]
Mathew 2003                                       eletriptan (low)             placebo 4.7134 [3.9351;  5.6456]
Mathew 2003                                       eletriptan (low)  sumatriptan (high) 1.2751 [1.0501;  1.5483]
Mathew 2003                                                placebo  sumatriptan (high) 0.2705 [0.2406;  0.3042]
Mathew 2007                                     almotriptan (high)             placebo 2.6575 [2.1239;  3.3251]
MOMENTUM 2019                                              placebo  rizatriptan (high) 0.2216 [0.1869;  0.2628]
Moon 2010                                             frovatriptan             placebo 3.2109 [2.2089;  4.6675]
Munjal 2017                                              celecoxib             placebo 1.8111 [1.2383;  2.6489]
Myllylä 1998                                               placebo  sumatriptan (high) 0.2705 [0.2406;  0.3042]
Nappi 1994                                                 placebo  sumatriptan (high) 0.2705 [0.2406;  0.3042]
NCT00920686 2010                                           placebo  sumatriptan (high) 0.2705 [0.2406;  0.3042]
NCT01248468 2011                                           placebo  sumatriptan (high) 0.2705 [0.2406;  0.3042]
NCT01657370 2012                                           placebo   ubrogepant (high) 0.4794 [0.3154;  0.7284]
NCT01657370 2012                                           placebo    ubrogepant (low) 0.5312 [0.3748;  0.7529]
NCT01657370 2012                                 ubrogepant (high)    ubrogepant (low) 1.1081 [0.7496;  1.6382]
NCT01986270 / 104 1998                           eletriptan (high)    eletriptan (low) 1.4620 [1.2146;  1.7597]
NCT01986270 / 104 1998                           eletriptan (high)             placebo 6.8908 [5.5576;  8.5440]
NCT01986270 / 104 1998                            eletriptan (low)             placebo 4.7134 [3.9351;  5.6456]
NCT03235479 2018                                           placebo          rimegepant 0.5120 [0.4027;  0.6508]
Nett 2003                                                  placebo  sumatriptan (high) 0.2705 [0.2406;  0.3042]
Nett 2003                                                  placebo   sumatriptan (low) 0.3163 [0.2748;  0.3641]
Nett 2003                                       sumatriptan (high)   sumatriptan (low) 1.1692 [1.0082;  1.3560]
Pascual 2000a                                   almotriptan (high)   almotriptan (low) 1.3962 [0.9681;  2.0137]
Pascual 2000a                                   almotriptan (high)             placebo 2.6575 [2.1239;  3.3251]
Pascual 2000a                                    almotriptan (low)             placebo 1.9033 [1.2847;  2.8199]
Pascual 2000b                                              placebo  rizatriptan (high) 0.2216 [0.1869;  0.2628]
Pascual 2000b                                              placebo  zolmitriptan (low) 0.3113 [0.2580;  0.3757]
Pascual 2000b                                   rizatriptan (high)  zolmitriptan (low) 1.4046 [1.1066;  1.7829]
Prior 2010                                      paracetamol (high)             placebo 2.1186 [1.3210;  3.3979]
Rapoport 1997                                              placebo zolmitriptan (high) 0.2585 [0.2021;  0.3307]
Rapoport 1997                                              placebo  zolmitriptan (low) 0.3113 [0.2580;  0.3757]
Rapoport 1997                                  zolmitriptan (high)  zolmitriptan (low) 1.2042 [0.9269;  1.5646]
Rapoport 2002                                         frovatriptan             placebo 3.2109 [2.2089;  4.6675]
Ryan 2002a                                            frovatriptan             placebo 3.2109 [2.2089;  4.6675]
Ryan 2002b                                            frovatriptan             placebo 3.2109 [2.2089;  4.6675]
Ryan 2002c                                            frovatriptan             placebo 3.2109 [2.2089;  4.6675]
Ryan 2002c                                            frovatriptan  sumatriptan (high) 0.8686 [0.5948;  1.2685]
Ryan 2002c                                                 placebo  sumatriptan (high) 0.2705 [0.2406;  0.3042]
S2WB3002 1996                                   naratriptan (high)   naratriptan (low) 1.8930 [1.1607;  3.0872]
S2WB3002 1996                                   naratriptan (high)             placebo 1.9248 [1.4489;  2.5570]
S2WB3002 1996                                   naratriptan (high)  sumatriptan (high) 0.5207 [0.3882;  0.6985]
S2WB3002 1996                                    naratriptan (low)             placebo 1.0168 [0.6249;  1.6544]
S2WB3002 1996                                    naratriptan (low)  sumatriptan (high) 0.2751 [0.1688;  0.4481]
S2WB3002 1996                                              placebo  sumatriptan (high) 0.2705 [0.2406;  0.3042]
Sakai 2002                                                 placebo zolmitriptan (high) 0.2585 [0.2021;  0.3307]
Sakai 2002                                                 placebo  zolmitriptan (low) 0.3113 [0.2580;  0.3757]
Sakai 2002                                     zolmitriptan (high)  zolmitriptan (low) 1.2042 [0.9269;  1.5646]
Sakai 2021                                       lasmiditan (high)    lasmiditan (low) 1.3411 [1.0580;  1.7000]
Sakai 2021                                       lasmiditan (high)             placebo 2.7119 [2.0936;  3.5130]
Sakai 2021                                        lasmiditan (low)             placebo 2.0221 [1.5664;  2.6105]
Sandrini 2002                                    eletriptan (high)    eletriptan (low) 1.4620 [1.2146;  1.7597]
Sandrini 2002                                    eletriptan (high)             placebo 6.8908 [5.5576;  8.5440]
Sandrini 2002                                    eletriptan (high)  sumatriptan (high) 1.8642 [1.4857;  2.3391]
Sandrini 2002                                    eletriptan (high)   sumatriptan (low) 2.1797 [1.7102;  2.7780]
Sandrini 2002                                     eletriptan (low)             placebo 4.7134 [3.9351;  5.6456]
Sandrini 2002                                     eletriptan (low)  sumatriptan (high) 1.2751 [1.0501;  1.5483]
Sandrini 2002                                     eletriptan (low)   sumatriptan (low) 1.4909 [1.2035;  1.8470]
Sandrini 2002                                              placebo  sumatriptan (high) 0.2705 [0.2406;  0.3042]
Sandrini 2002                                              placebo   sumatriptan (low) 0.3163 [0.2748;  0.3641]
Sandrini 2002                                   sumatriptan (high)   sumatriptan (low) 1.1692 [1.0082;  1.3560]
Saper 2006                                        ibuprofen (high)             placebo 2.1077 [1.4530;  3.0573]
Sargent 1995                                               placebo  sumatriptan (high) 0.2705 [0.2406;  0.3042]
Sargent 1995                                               placebo   sumatriptan (low) 0.3163 [0.2748;  0.3641]
Sargent 1995                                    sumatriptan (high)   sumatriptan (low) 1.1692 [1.0082;  1.3560]
Savani 1999                                                placebo   sumatriptan (low) 0.3163 [0.2748;  0.3641]
Sheftell 2003                                    eletriptan (high)    eletriptan (low) 1.4620 [1.2146;  1.7597]
Sheftell 2003                                    eletriptan (high)             placebo 6.8908 [5.5576;  8.5440]
Sheftell 2003                                     eletriptan (low)             placebo 4.7134 [3.9351;  5.6456]
Sheftell 2005a                                             placebo  sumatriptan (high) 0.2705 [0.2406;  0.3042]
Sheftell 2005a                                             placebo   sumatriptan (low) 0.3163 [0.2748;  0.3641]
Sheftell 2005a                                  sumatriptan (high)   sumatriptan (low) 1.1692 [1.0082;  1.3560]
Sheftell 2005b                                             placebo  sumatriptan (high) 0.2705 [0.2406;  0.3042]
Sheftell 2005b                                             placebo   sumatriptan (low) 0.3163 [0.2748;  0.3641]
Sheftell 2005b                                  sumatriptan (high)   sumatriptan (low) 1.1692 [1.0082;  1.3560]
Smith 2005                                   naproxen sodium (low)             placebo 2.1927 [1.6172;  2.9730]
Smith 2005                                   naproxen sodium (low)   sumatriptan (low) 0.6936 [0.5053;  0.9519]
Smith 2005                                                 placebo   sumatriptan (low) 0.3163 [0.2748;  0.3641]
Solomon 1997                                               placebo  zolmitriptan (low) 0.3113 [0.2580;  0.3757]
Spierings 2001                                  almotriptan (high)   sumatriptan (low) 0.8406 [0.6587;  1.0727]
Stark 2002                                       eletriptan (high)    eletriptan (low) 1.4620 [1.2146;  1.7597]
Stark 2002                                       eletriptan (high)             placebo 6.8908 [5.5576;  8.5440]
Stark 2002                                        eletriptan (low)             placebo 4.7134 [3.9351;  5.6456]
Steiner 2003                                     eletriptan (high)    eletriptan (low) 1.4620 [1.2146;  1.7597]
Steiner 2003                                     eletriptan (high)             placebo 6.8908 [5.5576;  8.5440]
Steiner 2003                                     eletriptan (high)  zolmitriptan (low) 2.1453 [1.6509;  2.7878]
Steiner 2003                                      eletriptan (low)             placebo 4.7134 [3.9351;  5.6456]
Steiner 2003                                      eletriptan (low)  zolmitriptan (low) 1.4674 [1.1548;  1.8646]
Steiner 2003                                               placebo  zolmitriptan (low) 0.3113 [0.2580;  0.3757]
SUM20033 2003                                              placebo  sumatriptan (high) 0.2705 [0.2406;  0.3042]
Tazaki 1993                                                placebo  sumatriptan (high) 0.2705 [0.2406;  0.3042]
Teall 1996                                                 placebo  rizatriptan (high) 0.2216 [0.1869;  0.2628]
Teall 1996                                                 placebo   rizatriptan (low) 0.3169 [0.2500;  0.4017]
Teall 1996                                      rizatriptan (high)   rizatriptan (low) 1.4299 [1.1337;  1.8035]
Tfelt-Hansen 1995                                          placebo  sumatriptan (high) 0.2705 [0.2406;  0.3042]
Tfelt-Hansen 1998                                          placebo  rizatriptan (high) 0.2216 [0.1869;  0.2628]
Tfelt-Hansen 1998                                          placebo   rizatriptan (low) 0.3169 [0.2500;  0.4017]
Tfelt-Hansen 1998                                          placebo  sumatriptan (high) 0.2705 [0.2406;  0.3042]
Tfelt-Hansen 1998                               rizatriptan (high)   rizatriptan (low) 1.4299 [1.1337;  1.8035]
Tfelt-Hansen 1998                               rizatriptan (high)  sumatriptan (high) 1.2205 [1.0058;  1.4811]
Tfelt-Hansen 1998                                rizatriptan (low)  sumatriptan (high) 0.8536 [0.6640;  1.0974]
Tfelt-Hansen 2006                                          placebo   sumatriptan (low) 0.3163 [0.2748;  0.3641]
Toledano 2021                                    paracetamol (low)             placebo 1.6000 [0.3900;  6.5649]
Visser 1996a                                               placebo  rizatriptan (high) 0.2216 [0.1869;  0.2628]
Visser 1996a                                               placebo  sumatriptan (high) 0.2705 [0.2406;  0.3042]
Visser 1996a                                    rizatriptan (high)  sumatriptan (high) 1.2205 [1.0058;  1.4811]
Visser 1996b                                               placebo zolmitriptan (high) 0.2585 [0.2021;  0.3307]
Voss 2016                                                  placebo   ubrogepant (high) 0.4794 [0.3154;  0.7284]
Voss 2016                                                  placebo    ubrogepant (low) 0.5312 [0.3748;  0.7529]
Voss 2016                                        ubrogepant (high)    ubrogepant (low) 1.1081 [0.7496;  1.6382]
Wentz 2008                                  naproxen sodium (high)             placebo 5.4321 [2.0638; 14.2978]
Winner 2003a                                               placebo  sumatriptan (high) 0.2705 [0.2406;  0.3042]
Winner 2003a                                               placebo   sumatriptan (low) 0.3163 [0.2748;  0.3641]
Winner 2003a                                    sumatriptan (high)   sumatriptan (low) 1.1692 [1.0082;  1.3560]
Winner 2003b                                               placebo  sumatriptan (high) 0.2705 [0.2406;  0.3042]
Winner 2003b                                               placebo   sumatriptan (low) 0.3163 [0.2748;  0.3641]
Winner 2003b                                    sumatriptan (high)   sumatriptan (low) 1.1692 [1.0082;  1.3560]
Yu 2023                                                    placebo          rimegepant 0.5120 [0.4027;  0.6508]

Number of studies: k = 115
Number of pairwise comparisons: m = 244
Number of observations: o = 76375
Number of treatments: n = 29
Number of designs: d = 50

Common effects model

Treatment estimate (sm = 'OR', comparison: other treatments vs 'placebo'):
                           OR            95%-CI     z  p-value
acetylsalicylic acid   2.5421 [1.8682;  3.4591]  5.94 < 0.0001
almotriptan (high)     2.5454 [2.1931;  2.9544] 12.29 < 0.0001
almotriptan (low)      1.7504 [1.3401;  2.2864]  4.11 < 0.0001
celecoxib              1.7619 [1.3630;  2.2775]  4.32 < 0.0001
diclofenac potassium   2.9738 [2.0423;  4.3301]  5.68 < 0.0001
eletriptan (high)      6.6529 [5.7087;  7.7532] 24.27 < 0.0001
eletriptan (low)       4.6857 [4.1317;  5.3141] 24.06 < 0.0001
frovatriptan           2.7680 [2.0505;  3.7364]  6.65 < 0.0001
ibuprofen (high)       1.8641 [1.4262;  2.4364]  4.56 < 0.0001
ibuprofen (low)        1.7426 [1.1371;  2.6705]  2.55   0.0108
lasmiditan (high)      2.5536 [2.1799;  2.9914] 11.61 < 0.0001
lasmiditan (low)       1.9056 [1.6359;  2.2198]  8.28 < 0.0001
naproxen sodium (high) 5.4321 [2.2610; 13.0510]  3.78   0.0002
naproxen sodium (low)  2.1743 [1.7486;  2.7036]  6.99 < 0.0001
naratriptan (high)     1.8703 [1.5019;  2.3290]  5.59 < 0.0001
naratriptan (low)      0.9767 [0.6532;  1.4603] -0.12   0.9084
paracetamol (high)     2.1031 [1.3969;  3.1662]  3.56   0.0004
paracetamol (low)      1.6000 [0.4144;  6.1769]  0.68   0.4953
phenazone              2.4129 [1.2022;  4.8426]  2.48   0.0132
placebo                     .                 .     .        .
rimegepant             1.9042 [1.6370;  2.2149]  8.35 < 0.0001
rizatriptan (high)     4.3377 [3.8366;  4.9042] 23.43 < 0.0001
rizatriptan (low)      2.9832 [2.5306;  3.5168] 13.02 < 0.0001
sumatriptan (high)     3.6639 [3.3647;  3.9897] 29.87 < 0.0001
sumatriptan (low)      3.1247 [2.8307;  3.4492] 22.60 < 0.0001
ubrogepant (high)      2.0555 [1.5382;  2.7468]  4.87 < 0.0001
ubrogepant (low)       1.7925 [1.4118;  2.2759]  4.79 < 0.0001
zolmitriptan (high)    3.6712 [3.1490;  4.2800] 16.61 < 0.0001
zolmitriptan (low)     3.0933 [2.7327;  3.5015] 17.86 < 0.0001

Random effects model

Treatment estimate (sm = 'OR', comparison: other treatments vs 'placebo'):
                           OR            95%-CI     z  p-value
acetylsalicylic acid   2.5609 [1.7460;  3.7562]  4.81 < 0.0001
almotriptan (high)     2.6575 [2.1239;  3.3251]  8.55 < 0.0001
almotriptan (low)      1.9033 [1.2847;  2.8199]  3.21   0.0013
celecoxib              1.8111 [1.2383;  2.6489]  3.06   0.0022
diclofenac potassium   3.0289 [1.8428;  4.9783]  4.37 < 0.0001
eletriptan (high)      6.8908 [5.5576;  8.5440] 17.59 < 0.0001
eletriptan (low)       4.7134 [3.9351;  5.6456] 16.84 < 0.0001
frovatriptan           3.2109 [2.2089;  4.6675]  6.11 < 0.0001
ibuprofen (high)       2.1077 [1.4530;  3.0573]  3.93 < 0.0001
ibuprofen (low)        1.9755 [1.1036;  3.5364]  2.29   0.0219
lasmiditan (high)      2.7119 [2.0936;  3.5130]  7.56 < 0.0001
lasmiditan (low)       2.0221 [1.5664;  2.6105]  5.40 < 0.0001
naproxen sodium (high) 5.4321 [2.0638; 14.2978]  3.43   0.0006
naproxen sodium (low)  2.1927 [1.6172;  2.9730]  5.05 < 0.0001
naratriptan (high)     1.9248 [1.4489;  2.5570]  4.52 < 0.0001
naratriptan (low)      1.0168 [0.6249;  1.6544]  0.07   0.9465
paracetamol (high)     2.1186 [1.3210;  3.3979]  3.11   0.0018
paracetamol (low)      1.6000 [0.3900;  6.5649]  0.65   0.5141
phenazone              2.4129 [1.0751;  5.4155]  2.14   0.0327
placebo                     .                 .     .        .
rimegepant             1.9533 [1.5366;  2.4830]  5.47 < 0.0001
rizatriptan (high)     4.5117 [3.8049;  5.3497] 17.33 < 0.0001
rizatriptan (low)      3.1553 [2.4893;  3.9996]  9.50 < 0.0001
sumatriptan (high)     3.6965 [3.2878;  4.1560] 21.87 < 0.0001
sumatriptan (low)      3.1614 [2.7467;  3.6388] 16.04 < 0.0001
ubrogepant (high)      2.0861 [1.3728;  3.1701]  3.44   0.0006
ubrogepant (low)       1.8825 [1.3283;  2.6680]  3.56   0.0004
zolmitriptan (high)    3.8681 [3.0243;  4.9473] 10.77 < 0.0001
zolmitriptan (low)     3.2121 [2.6615;  3.8765] 12.16 < 0.0001

Quantifying heterogeneity / inconsistency:
tau^2 = 0.0438; tau = 0.2093; I^2 = 41.7% [29.0%; 52.2%]

Tests of heterogeneity (within designs) and inconsistency (between designs):
                     Q d.f.  p-value
Total           254.01  148 < 0.0001
Within designs  136.25   91   0.0015
Between designs 117.76   57 < 0.0001

A total of 29 treatments are included in the network.
A total of 115 studies are included in this analysis.
A total of 76375 participants are included in this analysis, with 16207 events (21.22%).
Estimated heterogeneity tau-squared: 0.04.
Global test for inconsistency, p-value 0 (Q=118, d.o.f. 57)

The following studies were included in this analysis: 0462-039 1996 103 UN Ahrens 1999 Ashina 2021 Barbanti 2012 Bomhof 1999 Brandes 2005 Brandes 2007a Brandes 2007b Brauneis 1994 Bussone 2000 Cady 2006a Cady 2006b Cady 2009 Carpay 2004 Croop 2019 Cutler 1995 Dahlöf 1998 Dahlöf 2001 Dahlöf 2009 Diener 2002 Diener 2004 Diener 2005 Diener 2011 Dodick 2019 Dowson 2002a Dowson 2002b Eletriptan Steering Committee in Japan 2002 Ensink 1991 Färkkila 2003 Färkkila 2012 Freitag 2008 Garcia-Ramos 2003 Geraud 2000 Gijsmant 1997 Goadsby 2000 Goadsby 2007 Goadsby 2008 Goadsby 2019 Göbel 2004 Goldstein 2006 Gomez-Mancilla 2014 Gruffyd-Jones 2001 Ho 2008a Ho 2008b Jelinski 2006 Kaniecki 2006 Kellstein 2000 Klapper 2004 Klassen 1997 Kramer 1998 Kuca 2018 Landy 2004 Lange 2000 Lines 2001 Lipton 2000 Lipton 2005 Lipton 2010 Lipton 2019a Lipton 2019b Lipton 2019c Lipton 2021 Loder 2005 Marcus 2014 Massiou 2005 Mathew 2003 Mathew 2007 MOMENTUM 2019 Moon 2010 Munjal 2017 Myllylä 1998 Nappi 1994 NCT00920686 2010 NCT01248468 2011 NCT01657370 2012 NCT01986270 / 104 1998 NCT03235479 2018 Nett 2003 Pascual 2000a Pascual 2000b Prior 2010 Rapoport 1997 Rapoport 2002 Ryan 2002a Ryan 2002b Ryan 2002c S2WB3002 1996 Sakai 2002 Sakai 2021 Sandrini 2002 Saper 2006 Sargent 1995 Savani 1999 Sheftell 2003 Sheftell 2005a Sheftell 2005b Smith 2005 Solomon 1997 Spierings 2001 Stark 2002 Steiner 2003 SUM20033 2003 Tazaki 1993 Teall 1996 Tfelt-Hansen 1995 Tfelt-Hansen 1998 Tfelt-Hansen 2006 Toledano 2021 Visser 1996a Visser 1996b Voss 2016 Wentz 2008 Winner 2003a Winner 2003b Yu 2023.

File created on 2023-07-23.
